Viva Biotech Holdings reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 2,104.08 million compared to CNY 696.96 million a year ago. Net income was CNY 287.55 million compared to net loss of CNY 386.88 million a year ago.

Basic earnings per share from continuing operations was CNY 0.15 compared to basic loss per share from continuing operations of CNY 0.25 a year ago. Diluted earnings per share from continuing operations was CNY 0.08 compared to diluted loss per share from continuing operations of CNY 0.25 a year ago.